Triggered-release nanocapsules for drug delivery to the lungs

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 1, 2015, Pages 89-97

  Chana, Jasminder ^a   Forbes, Ben ^a   Jones, Stuart A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Lipid nanocapsules; Nanomedicines; Permeabilisation; Pluronic surfactant; Pulmonary drug delivery

Indexed keywords

BIOCOMPATIBILITY; DRUG DELIVERY; SURFACE ACTIVE AGENTS;

LIPID NANOCAPSULES; NANOMEDICINES; PERMEABILISATION; PLURONICS; PULMONARY DRUG DELIVERY;

NANOCAPSULES;

NANOCAPSULE; POLOXAMER; BIOMATERIAL; DRUG CARRIER; ELECTROLYTE; LIPID; RHODAMINE; RHODAMINE 6G; SURFACTANT;

AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; CELL INTERACTION; CELL SPECIFICITY; CONTROLLED STUDY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG RELEASE; EPITHELIUM CELL; FEASIBILITY STUDY; HUMAN; HUMAN CELL; PERMEABILITY; BRONCHUS; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DEVICES; INFRARED SPECTROPHOTOMETRY; INFRARED SPECTROSCOPY; INHALATIONAL DRUG ADMINISTRATION; LUNG; NANOMEDICINE; PATHOLOGY; PROCEDURES; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, INHALATION; BIOCOMPATIBLE MATERIALS; BRONCHI; CELL SURVIVAL; DRUG CARRIERS; ELECTROLYTES; EPITHELIAL CELLS; HUMANS; LIPIDS; LUNG; MICROSCOPY, ELECTRON, TRANSMISSION; NANOCAPSULES; NANOMEDICINE; PERMEABILITY; POLOXAMER; RHODAMINES; SPECTROPHOTOMETRY, INFRARED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE-ACTIVE AGENTS;

EID: 84919625486     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.07.012     Document Type: Article

References (49)

1. Zeng X.M., Martin G.P., Marriott C. The controlled delivery of drugs to the lung. Int J Pharm 1995, 124:149-164.
2. Lai S.K., Wang Y., Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009, 61:158-171.
3. Geiser M. Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv 2010, 23:207-217.
4. Rudt S., Muller R. In vitro phagocytosis assay of nanoparticles and microparticles by chemiluminescence. 1. Effect of analytical parameters, particle-size and particle concentration. J Control Release 1992, 22:263-271.
5. Beyerle A., Braun A., Banerjee A., Ercal N., Eickelberg O., Kissel T., et al. Inflammatory responses to pulmonary application of PEI-based siRNA nanocarriers in mice. Biomaterials 2011, 32:8694-8701.
6. Zhao Y., Brown M.B., Jones S.A. Pharmaceutical foams: are they the answer to the dilemma of topical nanoparticles?. Nanomedicine 2010, 6:227-236.
7. Zhu Z., Gao N., Wang H., Sukhishvili S. Temperature triggered on-demand drug release enables by hydrogen-bonded multilayers of block copolymer micelles. J Control Release 2013, 171:73-80.
8. Holme M.N., Fedotenko I.A., Abegg D., Althaus J., Babel L., Favarger F., et al. Shear-stress sensitive lenticular vesicles for targeted drug delivery. Nat Nanotechnol 2012, 7:536-543.
9. Todoroff J., Vanbever R. Fate of nanomedicines in the lungs. Curr Opin Colloid Interface Sci 2011, 16:246-254.
10. Kim J.C., Chungt Y.I., Kim Y.H., Tae G. The modulation of the permeability and the cellular uptake of liposome by stable anchoring of lipid-conjugated pluronic on liposome. J Biomed Nanotechnol 2014, 10:100-108.
11. O'Connor B.M., Lewis S.A., Borys N. Initial results of a phase I/II study evaluating the maximum tolerated dose, pharmacokinetics, safety, and efficacy of hyperthermia and lyso-thermosensitive liposomal (LTSL) doxorubicin in patients with breast cancer recurrence at the chest wall (RCW). Int J Radiat Oncol Biol Phys 2010, 78:S254-S255.
12. Lo P.K., Karam P., Aldaye F.A., McLaughlin C.K., Hamblin G.D., Cosa G., et al. Loading and selective release of cargo in DNA nanotubes with longitudinal variation. Nat Chem 2010, 2:319-328.
13. Lee S., Lee O., O'Halloran T.V., Schatz G.C., Nguyen S.T. Triggered release of pharmacophores from [Ni(HAsO3)]-loaded polymer-caged nanobin enhances pro-apoptotic activity: A combined experimental and theoretical study. ACS Nano 2011, 5:3961-3969.
14. Lin Y., Sonaje K., Lin K.M., Juang J., Mi F., Yang H., et al. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J Control Release 2008, 132:141-149.
15. Staff R.H., Gallei M., Mazurowski M., Rehahn M., Berger R., Landfester K., et al. Patchy nanocapsules of poly(vinylferrocene)-based block copolymers for redox-responsive release. ACS Nano 2012, 6:9042-9049.
16. Ding J., Xu W., Zhang Y., Sun D., Xiao C., Liu D., et al. Self-reinforced endocytoses of smart polypeptide nanogels for "on-demand" drug delivery. J Control Release 2013, 172:444-455.
17. Fong W., Hanley T., Boyd B. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo. J Control Release 2009, 135:218-226.
18. Xiong M., Bao Y., Yang X., Sun B., Wang J. Lipase sensitive polymeric triple-layered nanogel for "on-demand" drug delivery. J Am Chem Soc 2012, 134:4355-4362.
19. Braithwaite P, Williams S. Inhaler. Patent. WO2000GB04623. 2000.
20. Memoli A., Annesini M.C., Petralito S. Surfactant-induced leakage from liposomes: a comparison among different lecithin vesicles. Int J Pharm 1999, 184:227-235.
21. Zhao Y., Moddaresi M., Jones S.A., Brown M.B. A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ. Eur J Pharm Biopharm 2009, 72:521-528.
22. Jenning V., Schafer-Korting M., Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use drug release properties. J Control Release 2000, 66:115-126.
23. Zur Muhlen A., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur J Pharm Biopharm 1998, 45:149-155.
24. Occhipinti P., Griffiths P.C. Quantifying diffusion in mucosal systems by pulsed-gradient spin-echo NMR. Adv Drug Deliv Rev 2008, 60:1570-1582.
25. Demina T., Grozdova I., Krylova O., Zhirnov A., Istratov V., Frey H., et al. Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers. Biochemistry 2005, 44:4042-4054.
26. Lai S.K., Wang Y., Hida K., Cone R., Hanes J. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci U S A 2010, 107:598-603.
27. Bovis M.J., Woodhams J.H., Loizidou M., Scheglmann D., Bown S.G., MacRobert A.J. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. J Control Release 2012, 157:196-205.
28. Szebeni J., Bedocs P., Urbanics R., Buenger R., Rosivall L., Toth M., et al. Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: a porcine model. J Control Release 2012, 160:382-387.
29. Firestone M.A., Wolf A.C., Seifert S. Small-angle x-ray scattering study of the interaction of poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) triblock copolymers with lipid bilayers. Biomacromolecules 2003, 4:1539-1549.
30. Heurtault B., Saulnier P., Pech B., Proust J.E., Benoit J.P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 2002, 19:875-880.
31. Jones M.C., Jones S.A., Riffo Vasquez Y., Spina D., Hoffman E., Morgan A., et al. Qualitative assessment of nanoparticle surface hydrophobicity and its influence on pulmonary biocompatibility. J Control Release 2014, 183:94-104.
32. Tronde A., Norden B., Jeppson A.-B., Brunmark P., Nilsson E., Lennernas H., et al. Drug absorption from the isolated perfused rat lung-correlations with drug physicochemical properties and epithelial permeability. J Drug Target 2003, 11:61-74.
33. Grainger C.I., Greenwell L.L., Lockley D.J., Martin G.P., Forbes B. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm Res 2006, 23:1482-1490.
34. Grenha A., Grainger C.I., Dailey L.A., Seijo B., Martin G.P., Remunan-Lopez C., et al. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. Eur J Pharm Sci 2007, 31:73-84.
35. Kozlov M.Y., Melik-Nubarov N.S., Batrakova E.V., Kabanov A.V. Relationship between pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes. Macromolecules 2000, 33:3305-3313.
36. Baker J.A., Berg J.C. Investigation of the adsorption configuration of poly(ethylene oxide) and its copolymers with poly(propylene oxide) on model polystyrene latex dispersions. Langmuir 1988, 4:1055-1061.
37. Kayes J.B., Rawlins D.A. Adsorption characteristics of certain polyoxyethylene-polyoxypropylene block co-polymers on polystyrene latex. Colloid Polym Sci 1979, 257:622-629.
38. Johnsson M., Silvander M., Karlsson G., Edwards K. Effect of PEO-PPO-PEO triblock copolymers on structure and stability of phosphatidylcholine liposomes. Langmuir 1999, 15:6314-6325.
39. Boncheva M., Damien F., Normand V. Molecular organization of the lipid matrix in intact Stratum corneum using ATR-FTIR spectroscopy. Biochim Biophys Acta Biomembr 2008, 1778:1344-1355.
40. Harrison J.E., Groundwater P.W., Brain K.R., Hadgraft J. Azone(R) induced fluidity in human stratum corneum. A Fourier transform infrared spectroscopy investigation using the perdeuterated analogue. J Control Release 1996, 41:283-290.
41. Blume A. Properties of lipid vesicles: FT-IR spectroscopy and fluorescence probe studies. Curr Opin Colloid Interface Sci 1996, 1:64-77.
42. Mantsch H.H., Mcelhaney R.N. Phospholipid phase-transitions in model and biological-membranes as studied by infrared-spectroscopy. Chem Phys Lipids 1991, 57:213-226.
43. Abdel-Mottaleb M.M.A., Neumann D., Lamprecht A. In vitro drug release mechanism from lipid nanocapsules (LNC). Int J Pharm 2010, 390:208-213.
44. Lamprecht A., Bouligand Y., Benoit J.P. New lipid nanocapsules exhibit sustained release properties for amiodarone. J Control Release 2002, 84:59-68.
45. Almgren M., Brown W., Hvidt S. Self-aggregation and phase-behavior of poly(ethylene oxide) poly(propylene oxide) poly(ethylene oxide) block-copolymers in aqueous-solution. Colloid Polym Sci 1995, 273:2-15.
46. Alexandridis P., Zhou D.L., Khan A. Lyotropic liquid crystallinity in amphiphilic block copolymers: temperature effects on phase behavior and structure for poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) copolymers of different composition. Langmuir 1996, 12:2690-2700.
47. Desai P.R., Jain N.J., Bahadur P. Anomalous clouding behavior of an ethylene oxide-propylene oxide block copolymer in aqueous solution. Colloid Surf A 2002, 197:19-26.
48. Mata J.P., Majhi P.R., Guo C., Liu H.Z., Bahadur P. Concentration, temperature, and salt-induced micellization of a triblock copolymer Pluronic L64 in aqueous media. J Colloid Interface Sci 2005, 292:548-556.
49. Patel K., Bahadur P., Guo C., Ma J.H., Liu H.Z., Yamashita Y., et al. Salt induced micellization of very hydrophilic PEO-PPO-PEO block copolymers in aqueous solutions. Eur Polym J 2007, 43:1699-1708.